Division of Angiology, Heart and Vessel Department, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Institute of Social Sciences, University of Lausanne, Lausanne, Switzerland.
Nutr Metab Cardiovasc Dis. 2023 Aug;33(8):1546-1555. doi: 10.1016/j.numecd.2023.04.019. Epub 2023 May 3.
The ultrasonographic detection of subclinical atherosclerosis (scATS) at carotid and femoral vascular sites using the atherosclerosis burden score (ABS) improves the risk stratification for atherosclerotic cardiovascular disease beyond traditional cardiovascular (CV) risk factors. However, its predictive value should be further enhanced. We hypothesize that combining the ABS and the Framingham risk score (FHRS) to create a new score called the FHRABS will improve CV risk prediction and prevention. We aim to investigate if incorporating the ABS into the FHRS improved CV risk prediction in a primary prevention setting.
1024 patients were included in this prospective observational cohort study. Carotid and femoral plaques were ultra-sonographic detected. Major incident cardiovascular events (MACEs) were collected. The receiver operating characteristic curve (ROC-AUC) and Youden's index (Ysi) were used to compare the incremental contributions of each marker to predict MACEs. After a median follow-up of 6.0 ± 3.3 years, 60 primary MACEs (5.8%) occurred. The ROC-AUC for MACEs prediction was significantly higher for the FHRABS (0.74, p < 0.024) and for the ABS (0.71, p < 0.013) compared to the FHRS alone (0.71, p < 0.46). Ysi or the FHRABS (42%, p < 0.001) and ABS (37%, p < 0.001) than for the FHRS (31%). Cox proportional-hazard models showed that the CV predictive performance of FHRS was significantly enhanced by the ABS (10.8 vs. 5.5, p < 0.001) and FHRABS (HR 23.30 vs. 5.50, p < 0.001).
FHRABS is a useful score for improving CV risk stratification and detecting patients at high risk of future MACEs. FHRABS offers a simple-to-use, and radiation-free score with which to detect scATS in order to promote personalized CV prevention.
通过动脉粥样硬化负担评分(ABS)在颈动脉和股血管部位对亚临床动脉粥样硬化(scATS)的超声检测,可改善动脉粥样硬化性心血管疾病的风险分层,超出传统心血管(CV)危险因素的范围。然而,其预测价值应该进一步提高。我们假设,将 ABS 与弗雷明汉风险评分(FHRS)相结合,创建一个新的评分,称为 FHRABS,将改善 CV 风险预测和预防。我们旨在研究在一级预防环境中,将 ABS 纳入 FHRS 是否可以改善 CV 风险预测。
本前瞻性观察队列研究纳入了 1024 例患者。对颈动脉和股动脉斑块进行超声检测。收集主要心血管不良事件(MACEs)。使用受试者工作特征曲线(ROC-AUC)和 Youden 指数(Ysi)比较每个标志物对预测 MACEs 的增量贡献。中位随访 6.0±3.3 年后,发生 60 例原发性 MACEs(5.8%)。与 FHRS 单独相比,MACEs 预测的 FHRABS(0.74,p<0.024)和 ABS(0.71,p<0.013)的 ROC-AUC 显著更高(0.71,p<0.46)。Ysi 或 FHRABS(42%,p<0.001)和 ABS(37%,p<0.001)均高于 FHRS(31%)。Cox 比例风险模型显示,ABS(10.8 比 5.5,p<0.001)和 FHRABS(HR 23.30 比 5.50,p<0.001)显著增强了 FHRS 的 CV 预测性能。
FHRABS 是一种有用的评分,可改善 CV 风险分层,并检测出未来发生 MACEs 的高危患者。FHRABS 提供了一种简单易用且无辐射的评分,可用于检测 scATS,以促进个性化 CV 预防。